A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| EDTA Na2 | EDTA Na2. CAS No: 6381-92-6 |  Sarchem Laboratories New Jersey NJ |
| EDTA Tetrasodium Salt | White powder. Uses: detergents, cosmetics. Group: organic salt. Alternative Names: Tetrasodium EDTA. CAS No. 13235-36-4. |  |
| EDTA Tetrasodium Salt 13235-36-4 | EDTA Tetrasodium Salt - Surface Coatings. SUPPLIERS TO BUSINESS CUSTOMERS ONLY. |  North America & APAC |
| EDTA Tetrasodium Salt 13235-36-4 | EDTA Tetrasodium Salt - Surface Coatings. SUPPLIERS TO BUSINESS CUSTOMERS ONLY. New1103 | North America & APAC |
| EDTA tetrasodium salt dihydrate | 100g Pack Size. Group: Biochemicals, Ligands. Formula: C10H12N2O8Na4 ·2H2O. CAS No. 10378-23-1. Prepack ID 54799339-100g. Molecular Weight 416.2. See USA prepack pricing. |  |
| EDTA tetrasodium salt dihydrate | 1kg Pack Size. Group: Biochemicals, Ligands. Formula: C10H12N2O8Na4 ·2H2O. CAS No. 10378-23-1. Prepack ID 54799339-1kg. Molecular Weight 416.2. See USA prepack pricing. | |
| EDTA Tetrasodium Salt Dihydrate | EDTA Tetrasodium Salt Dihydrate . CAS No. 10378-23-1. Molecular Formula C10H12N2Na4O8 * 2H2O. Chemical Reagents |  Cater Chemicals Corp. Illinois IL |
| EDTA, Tetrasodium Tetrahydrate Salt - CAS 13235-36-4 | Organic chelating agent used in ion exchange, metal chelation, antioxidation procedures, spectrophotometric titration, and other chemical procedures. Group: Fluorescence/luminescence spectroscopy. |  |
| EDTA tripotassium salt | 100g Pack Size. Group: Ligands. Formula: C10H13K3N2O8. CAS No. 17572-97-3. Prepack ID 52369963-100g. Molecular Weight 406.51. See USA prepack pricing. | |
| EDTA tripotassium salt dihydrate | 100g Pack Size. Group: Amines, Analytical Reagents, Organics, Research Organics & Inorganics. Formula: (KOOCCH2)2NCH2CH2N(CH2COOK)CH2COOH · 2H2O. CAS No. 65501-24-8. Prepack ID 22510944-100g. Molecular Weight 442.54. See USA prepack pricing. | |
| EDTA Tripotassium Salt Dihydrate | EDTA Tripotassium Salt Dihydrate. CAS No. 65501-24-8. Molecular Formula C10H13N2O8 3K * 2H2O. Chemical Reagents | Cater Chemicals Corp. Illinois IL |
| EDTA trisodium salt dihydrate | 100g Pack Size. Group: Biochemicals, Ligands. Formula: C10H13N2O8Na3 ·2H2O. CAS No. 150-38-9. Prepack ID 22971931-100g. Molecular Weight 394.22. See USA prepack pricing. | |
| EDTA Trisodium Salt Trihydrate | ~99%. Group: Biochemicals. Alternative Names: Ethylene diaminetetraacetic acid, trisodium trihydrate. Grades: Molecular Biology Grade. CAS No. 65501-25-9 (150-38-9 anhydrous). Pack Sizes: 500g, 1Kg. US Biological Life Sciences. |  Worldwide |
| EDTA Trisodium Trihydrate | EDTA Trisodium Trihydrate. CAS No. 150-38-9. Chemical Reagents | Cater Chemicals Corp. Illinois IL |
| Edunol | 3-hydroxy-2-isopentenyl-8,9-methylenedioxypterocarpan (6aS, 11aS-form). CAS No. 37706-60-8. Product ID: 2-08145. Molecular formula: C21H20O5. Mole weight: 352.4. Purity: >95%. Source : (Pterocarpan from Neorautanenia amboensis). |  |
| Ee-CBP | Ee-CBP is a hevein-type antimicrobial peptide from bark of the spindle tree (Euonymus europaeus L.). |  |
| EED226 | EED226 is a polycomb repressive complex 2 (PRC2) inhibitor, which binds to the K27me3-pocket on embryonic ectoderm development (EED) and shows strong antitumor activity in xenograft mice model[1]. EED226 is a potent, selective, and orally bioavailable EED inhibitor[2]. EED226 inhibits PRC2 with an IC50 of 23.4 nM when the H3K27me0 peptide is used as a substrate in the in vitro enzymatic assays[3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2083627-02-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-101117. |  |
| EED-226 | EED-226 is a novel allosteric Polycomb repressive complex 2 (PRC2) inhibitor (IC50 = 23.4 nM when the substrate is H3K27me0 peptide and IC50 = 53.5 nM when the substrate is mononucleosom). EED-226 induces a conformational change via binding EED which invalidates PRC2 activity. PRC2 plays pivotal roles in transcriptional regulation. EED-226 has the potential to treat PRC2-dependent cancers, such as human lymphoma xenograft tumors. Synonyms: EED226; EED-226; EED 226. N-(2-furanylmethyl)-8-[4-(methylsulfonyl)phenyl]-1,2,4-triazolo[4,3-c]pyrimidin-5-amine. Grades: 98%. CAS No. 2083627-02-3. Molecular formula: C17H15N5O3S. Mole weight: 369.4. | |
| EED human | recombinant, expressed in baculovirus infected insect cells, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| E,E-Dienestrol | E,E-Dienestrol. Group: Biochemicals. Alternative Names: 3,4-Bis(4-hydroxyphenyl)-2,4-hexadiene; a-Dienestrol; 4,4'-[(1E,2E)-1,2-Diethylidene-1,2-ethanediyl]bis-phenol. Grades: Highly Purified. CAS No. 13029-44-2. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C18H18O2. US Biological Life Sciences. | Worldwide |
| E,E-Dienestrol (3,4-Bis(4-hydroxyphenyl)-2,4-hexadiene) | A metabolite of Diethylstilbestrol. Group: Biochemicals. Alternative Names: 3,4-Bis(4-hydroxyphenyl)-2,4-hexadiene. Grades: Highly Purified. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| EEDQ | EEDQ is a biochemical reagent that can be used as a biological material or organic compound for life science related research [1]. Uses: Scientific research. Group: Biochemical assay reagents. Alternative Names: EEDQ. CAS No. 16357-59-8. Pack Sizes: 25 g. Product ID: HY-Y1191. | |
| EEDQ (2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline) | 25g Pack Size. Group: Biochemicals, Building Blocks, Peptide Reagents. Formula: C14H17NO3. CAS No. 16357-59-8. Prepack ID 16764018-25g. Molecular Weight 247.29. See USA prepack pricing. | |
| EEDQ (2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline) | 100g Pack Size. Group: Biochemicals, Building Blocks, Peptide Reagents. Formula: C14H17NO3. CAS No. 16357-59-8. Prepack ID 16764018-100g. Molecular Weight 247.29. See USA prepack pricing. | |
| EEF2K, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| eEF-2 Kinase Inhibitor, NH125 - CAS 278603-08-0 | The eEF-2 Kinase Inhibitor, NH125, also referenced under CAS 278603-08-0, controls the biological activity of eEF-2 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| eEF2K Inhibitor, A-484954 (7-amino-1-cyclopropyl-3-ethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carboxamide, Eukaryotic Elongation Factor-2 Kinase Inhibitor, A-484954) | A cell-permeable pyrido-pyrimidinedione derivative that acts as a highly potent and selective inhibitor of eukaryotic elongation factor-2 kinase (eEF2K) (IC50=280nM). Exhibits very little activity against a broad panel of serine/threonine and protein tyrosine kinases. Inhibits eEF2 phosphorylation in multiple cell lines tested without affecting the net eEF2 levels. At concentration where it inhibits eEF2K activity, it has no effect on the proliferation of cancer cell lines.CAS No.142557-61-7. Group: Biochemicals. Grades: Highly Purified. CAS No. 142557-61-7. Pack Sizes: 10mg. Molecular Formula: C??H??N?O?, Molecular Weight: 289.3. US Biological Life Sciences. | Worldwide |
| eEF2K Inhibitor, A-484954 - CAS 142557-61-7 | The eEF2K Inhibitor, A-484954, also referenced under CAS 142557-61-7, controls the biological activity of eEF2K Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| Eeyarestatin I | Eeyarestatin I. Group: Biochemicals. Grades: Purified. CAS No. 412960-54-4. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Eeyarestatin I | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Eeyarestatin I | Eeyarestatin I is a potent inhibitor of endoplasmic reticulum associated protein degradation (ERAD). Eeyarestatin I suppresses ataxin-3 (atx3)-dependent deubiquitination targeting the p97-associated deubiquinating process (PAD). It also inhibits Sec61-mediated protein translocation at the ER. Eeyarestatin I exhibits cytotoxic activity against cancer cells. Synonyms: 3- (4-Chlorophenyl) -4-[[[ (4-chlorophenyl) amino]carbonyl]hydroxyamino]-5, 5-dimethyl-2-oxo-1-imidazolidineacetic acid 2-[3-(5-nitro-2-furanyl)-2-propen-1-ylidene]hydrazide. Grades: ≥98% by HPLC. CAS No. 412960-54-4. Molecular formula: C27H25Cl2N7O7. Mole weight: 630.44. | |
| Eeyarestatin I | Eeyarestatin I, a potent endoplasmic reticulum-associated protein degradation (ERAD) inhibitor, is a potent protein translocation inhibitor. Eeyarestatin I inhibits Sec61 translocon. Eeyarestatin I targets the p97-associated deubiquitinating process (PAD) and inhibits atx3-dependent deubiquitination. Eeyarestatin I interferes at a step prior to proteasomal degradation. Eeyarestatin I induces cell death via the proapoptotic protein NOXA and has anticancer effects[1][2][3][4][5]. Uses: Scientific research. Group: Signaling pathways. CAS No. 412960-54-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-110078. | |
| Eeyarestatin I | Eeyarestatin I. CAS No: 412960-54-4 | Sarchem Laboratories New Jersey NJ |
| EF24 | EF24, a curcumin analogue, is an NF-kB inhibitor with great anti-tumor efficacy and oral bioavailability via deactivation of the MAPK/ERK signaling pathway in oral squamous cell carcinoma (OSCC). EF24 is active against melanoma and breast cancer cell lines with GI50 values of 0.7 ?M and 0.8 ?M, respectively. EF24 induces cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells and DU-145 human prostate cancer cells. EF24 increases the levels of activated caspase 3 and 9, and decreases the phosphorylated forms of MEK1 and ERK[1][2][3][4]. Uses: Scientific research. Group: Signaling pathways. CAS No. 342808-40-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-119272. | |
| EF-24 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| EF5 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| EF-5 | EF-5 (EF5; 2-Nitroimidazole) is a hypoxia labeling agent used to identify hypoxia in cells. Uses: Scientific research. Group: Signaling pathways. CAS No. 152721-37-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-U00118. | |
| Efalizumab | Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a , the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 214745-43-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9947. | |
| Efaproxiral | Allosteric modifier of hemoglobin (HB). Binds in the central water cavity of the Hb molecule causing a conformational change such that bound oxygen is released more readily. Antineoplastic adjunct (radiosensitizer). Group: Biochemicals. Alternative Names: 2-[4-[2-[(3,5-Dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methylpropanoic Acid; RSR 13. Grades: Highly Purified. CAS No. 131179-95-8. Pack Sizes: 250mg. US Biological Life Sciences. | Worldwide |
| Efaproxiral | synthetic small molecule with radiosensitizing activity. Efaproxiral increases oxygen levels in hypoxic tumor tissues by binding non-covalently to the hemoglobin tetramer and decreasing hemoglobin-oxygen binding affinity. Increasing tumor oxygenation reduces tumor radioresistance. One use for efaproxiral is to increase the efficacy of certain chemotherapy drugs which have reduced efficacy against hypoxic tumours, and can thus be made more effective by increased offloading of oxygen into the tumour tissues. However, no benefit was seen for efaproxiral in phase III clinical trials. Synonyms: RSR13; RSR-13; RSR 13; Efaproxyn; NSC722758; (24 (35di methyl anilino) carbonyl methyl phenoxyl2 methyl proprionic acid sodium salt. CAS No. 131179-95-8. Molecular formula: C20H23NO4. Mole weight: 341.4. | |
| Efaproxiral | Efaproxiral is a haemoglobin (Hb) synthetic allosteric modifier, decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: RSR13. CAS No. 131179-95-8. Pack Sizes: 10 mM * 1 mL; 50 mg. Product ID: HY-13619. | |
| Efaproxiral sodium | Efaproxiral sodium (RSR13 sodium) is a synthetic allosteric modifier of haemoglobin (Hb), decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy. Uses: Scientific research. Group: Signaling pathways. Alternative Names: RSR13 sodium. CAS No. 170787-99-2. Pack Sizes: 10 mM * 1 mL; 50 mg. Product ID: HY-13619A. | |
| Efaproxiral Sodium | Efaproxiral, a synthetic allosteric modi?er of hemoglobinoxygen binding af?nity, has been shown to bind reversibly to hemoglobin, stabilizing the deoxyhemoglobin tetramer conformation to reduce its af?nity for oxygen. Synonyms: Efaproxiral sodium; 170787-99-2; RSR13 SODIUM; Sodium 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoate; Efaproxiral (sodium); Efaproxiral sodium [USAN]; RSR-13 SODIUM; 3L83QP52XI; 170787-99-2 (sodium); Efaproxyn; Efaproxiral sodium (USAN); Sodium 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methylpropanoate; Propanoic acid, 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methyl-, monosodium salt; Efaproxiral Sodium. Grades: >98%. CAS No. 170787-99-2. Molecular formula: C20H23NO4.Na. Mole weight: 363.38. | |
| Efaroxan hydrochloride | Efaroxan hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 89197-00-2. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Efaroxan hydrochloride | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Efaroxan hydrochloride | Efaroxan hydrochloride is a potent and selective α2 adrenoceptor antagonist and imidazoline I1 receptor ligand (pKi = 7.87, 7.42, 5.74, 7.28 and < 5 for α 2A, α2B, α2C, I1, and I2 receptors, respectively). Efaroxan promotes insulin secretion, at a site distinct from I1 or I2 (the putative I3 receptor) in vitro and in vivo. Synonyms: Efaroxan HCl; RX 821037A; RX821037A; RX-821037A; EU-0100521; EU0100521; EU 0100521; 2-(2-Ethyl-2,3-dihydro-2-benzofuranyl)-4,5-dihydro-1H-imidazole hydrochloride. Grades: ≥99% by HPLC. CAS No. 89197-00-2. Molecular formula: C13H16N2O.HCl. Mole weight: 252.74. | |
| Efavaleukin alfa | Efavaleukin alfa (AMG592) is a human monoclonal antibody. Efavaleukin alfa is composed of the IGHG1 Fc fragment fused to IL-2. The expression system of Efavaleukin alfa is usually CHO (Chinese Hamster Ovary) cells [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: AMG592. CAS No. 2049067-94-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99877. | |
| Efavirenz | Efavirenz (DMP 266) is a potent inhibitor of the wild-type HIV-1 reverse transcriptase with a K i of 2.93 nM and exhibits an IC 95 of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture [1]. Uses: Scientific research. Group: Natural products. Alternative Names: DMP 266; EFV; L-743726. CAS No. 154598-52-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg. Product ID: HY-10572. | |
| Efavirenz 1-Desamine | Efavirenz 1-Desamine is an analog of Efavirenz, a nonnucleoside HIV-1 reverse transcriptase inhibitor. Antiviral. Group: Biochemicals. Alternative Names: 7-Chloro-1- (cyclopropylethynyl) -1- (trifluoromethyl) isochroman-3-one. Grades: Highly Purified. Pack Sizes: 500ug, 1mg, 2.5mg. Molecular Formula: C15H10ClF3O2. US Biological Life Sciences. | Worldwide |
| Efavirenz Benzoylaminoalcohol Impurity | An impurity arising in the synthesis of Efavirenz. Synonyms: rac N-[4-Chloro-2-[3-cyclopropyl-1-hydroxy-1-(trifluoromethyl)-2-propynyl]phenyl]-4-methoxybenzamide. Grades: > 95%. CAS No. 1189491-03-9. Molecular formula: C21H17ClF3NO3. Mole weight: 423.81. | |
| Efavirenz impurity (6-chloro-4-[2-(2-methylcyclopropyl)ethynyl]-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | Efavirenz impurity (6-chloro-4-[2-(2-methylcyclopropyl)ethynyl]-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) is an impurity of Efavirenz, a medication used to treat HIV/AIDS. Grades: > 95%. CAS No. 1217623-65-8. Molecular formula: C15H11ClF3NO2. Mole weight: 329.71. | |
| Efavirenz impurity (6-chloro-4-(pent-1-ynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | Grades: > 95%. CAS No. 1627575-36-3. Molecular formula: C14H11ClF3NO2. Mole weight: 317.7. | |
| Efavirenz Pen-3-ene-1-yne. (cis/trans Mixture) | Efavirenz Pen-3-ene-1-yne(cis/trans Mixture). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 2.5mg. Molecular Formula: C14H9ClF3NO2, Molecular Weight: 315.67. US Biological Life Sciences. | Worldwide |
| Efavirenz Racemic | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardsimpurity standardspharmaceutical toxicology. Alternative Names: Efavirenz Racemic, ((+/-)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one). | |
| Efavirenz Ready Made Solution | 10 mg/mL in DMSO. Group: Fluorescence/luminescence spectroscopy. | |
| Efavirenz Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Efavirenz Related Compound A | Cas No. 209414-27-7. | |
| Efavirenz Related Compound B | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Efavirenz Related Compound B | Efavirenz impurity. Synonyms: (4S)-6-Chloro-4-[(1E)-2-cyclopropylethenyl]-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-Benzoxazin-2-one; USP Efavirenz Related Compound B. Grades: > 95%. CAS No. 440124-96-9. Molecular formula: C14H11ClF3NO2. Mole weight: 317.69. | |
| Efavirenz Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Efavirenz Related Compound C | An impurity of Efavirenz, a nonnucleoside HIV-1 reverse transcriptase inhibitor and antiviral agent. Synonyms: 2-Cyclopropyl-6-chloro-4-(trifluoromethyl)quinoline, USP Efavirenz Related Compound C. Grades: > 95%. CAS No. 391860-73-4. Molecular formula: C13H9ClF3N. Mole weight: 271.67. | |
| Efavirenz (Sustiva, MDP-266, L-743726) | A nonnucleoside HIV-1 reverse transcriptase inhibitor. Group: Biochemicals. Alternative Names: (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266; L 743726; Stocrin; Sustiva. Grades: Highly Purified. CAS No. 154598-52-4. Pack Sizes: 250mg, 500mg, 1g. Molecular Formula: C14H9ClF3NO2, Molecular Weight: 315.67. US Biological Life Sciences. | Worldwide |
| Efbemalenograstim alfa | Efbemalenograstim alfa (F 627) is a recombinant fusion protein. Efbemalenograstim alfa is a long acting dimeric granulocyte colony-stimulating factor (G-CSF) that contains two human G-CSF fused to a human immunoglobulin G2 (hIgG2)-Fc fragment with a peptide linker. Efbemalenograstim alfa induces the production of white blood cells [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Benegrastim; Bineuta; F 627. CAS No. 2200269-79-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99879. | |
| Effervellen impurity3 | Effervellen impurity3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1132642-95-5. Molecular formula: C14H4D5ClF3NO2. Mole weight: 320.71. Catalog: APB1132642955. | |
| Effusol | Effusol. Group: Biochemicals. Alternative Names: 5-Ethenyl-9,10-dihydro-1-methyl-2,7-phenanthrenediol; NSC 371300. Grades: Highly Purified. CAS No. 73166-28-6. Pack Sizes: 10mg. Molecular Formula: C17H16O2. US Biological Life Sciences. | Worldwide |
| EFIN | EFIN. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 9,9-Dimethyl-N,N-diphenyl-7-(4-(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl)-9H-fluoren-2-amine. Product Category: Organic Light Emitting Diode (OLED). CAS No. 1705571-72-7. Molecular formula: C46H35N3. Mole weight: 629.79 g/mol. Product ID: ACM1705571727. Alfa Chemistry ISO 9001:2015 Certified. Categories: Efinaconazole. |  |
| Efinaconazole | Efinaconazole is a topical antifungal for onychomycosis. Group: Biochemicals. Alternative Names: (αR, βR)-α-(2,4-Difluorophenyl)- β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol; [R-(R*,R*)]-α-(2,4-Difluorophenyl)- β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol; KP 103; KP 103. Grades: Highly Purified. CAS No. 164650-44-6. Pack Sizes: 500mg, 1g. Molecular Formula: C??H??F?N?O, Molecular Weight: 348.39. US Biological Life Sciences. | Worldwide |
| Efinaconazole | Efinaconazole is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole acts as a 14α-demethylase inhibitor. Efinaconazole inhibits fungal lanosterol 14α-demethylase involved in the biosynthesis of ergosterol, a constituent of fungal cell membranes. Efinaconazole has been shown to be active against isolates of the following microorganisms, both in vitro and in clinical infections. Efinaconazole exhibits in vitro minimum inhibitory concentrations (MICs) of 0.06 μg/mL or less against most ( ≥ 90%) isolates of the following microorganisms: Trichophyton rubrum; Trichophyton mentagrophytes. Synonyms: KP103; KP-103; KP 103; CTK5J2975; AGJ95634; KB145948; AGJ 95634; KB 145948; AGJ-95634; KB-145948; Efinaconazole; trade name: Jublia. Grades: >98%. CAS No. 164650-44-6. Molecular formula: C18H22F2N4O. Mole weight: 348.39. | |
| Efinaconazole | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopypharma & vet compounds & metabolitespharma & vet compounds & metabolites. Alternative Names: (?R,?R)-?-(2,4-Difluorophenyl)-?-methyl-4-methylene-?-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol, 1-Piperidineethanol, ?-(2,4-difluorophenyl)-?-methyl-4-methylene-?-(1H-1,2,4-triazol-1-ylmethyl)-, [R-(R*,R*)]-, Efinaconazole, KP 103, Jublia,1-Piperidineethanol, ?-(2,4-difluorophenyl)-?-methyl-4-methylene-?-(1H-1,2,4-triazol-1-ylmethyl)-, (?R,?R)-, KP 103 (pharmaceutical). | |
| Efinaconazole | Efinaconazole is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole acts as a 14α-demethylase inhibitor. Efinaconazole inhibits fungal lanosterol 14α-demethylase involved in the biosynthesis of ergosterol, a constituent of fungal cell membranes. Efinaconazole has been shown to be active against isolates of the following microorganisms, both in vitro and in clinical infections. Efinaconazole exhibits in vitro minimum inhibitory concentrations (MICs) of 0.06 μg/mL or less against most ( ≥ 90%) isolates of the following microorganisms: Trichophyton rubrum; Trichophyton mentagrophytes. Uses: Designed for use in research and industrial production. Additional or Alternative Names: KP103; KP-103; KP 103; CTK5J2975; AGJ95634; KB145948; Efinaconazole; trade name: Jublia. Product Category: Inhibitors. Appearance: Solid powder. CAS No. 164650-44-6. Molecular formula: C18H22F2N4O. Mole weight: 348.39. Purity: >98%. IUPACName: (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol. Canonical SMILES: C[C@@H](N1CCC(CC1)=C)[C@@](O)(C2=CC=C(F)C=C2F)CN3N=CN=C3. Product ID: ACM164650446. Alfa Chemistry ISO 9001:2015 Certified. | |
Our database is helping our users find suppliers everyday.
